Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression.

Banzola I, Mengus C, Wyler S, Hudolin T, Manzella G, Chiarugi A, Boldorini R, Sais G, Schmidli TS, Chiffi G, Bachmann A, Sulser T, Spagnoli GC, Provenzano M.

Front Immunol. 2018 May 29;9:1051. doi: 10.3389/fimmu.2018.01051. eCollection 2018.

2.

Gut microbiota modulate T cell trafficking into human colorectal cancer.

Cremonesi E, Governa V, Garzon JFG, Mele V, Amicarella F, Muraro MG, Trella E, Galati-Fournier V, Oertli D, Däster SR, Droeser RA, Weixler B, Bolli M, Rosso R, Nitsche U, Khanna N, Egli A, Keck S, Slotta-Huspenina J, Terracciano LM, Zajac P, Spagnoli GC, Eppenberger-Castori S, Janssen KP, Borsig L, Iezzi G.

Gut. 2018 Feb 6. pii: gutjnl-2016-313498. doi: 10.1136/gutjnl-2016-313498. [Epub ahead of print]

PMID:
29437871
3.

MAGE-A4 and MAGE-A1 Immunohistochemical Expression in High-grade Endometrial Cancer.

Srdelić S, Kuzmić-Prusac I, Spagnoli GC, Juretić A, Čapkun V.

Int J Gynecol Pathol. 2017 Nov 14. doi: 10.1097/PGP.0000000000000470. [Epub ahead of print]

PMID:
29140883
4.

mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition.

Xue G, Kohler R, Tang F, Hynx D, Wang Y, Orso F, Prêtre V, Ritschard R, Hirschmann P, Cron P, Roloff T, Dummer R, Mandalà M, Bichet S, Genoud C, Meyer AG, Muraro MG, Spagnoli GC, Taverna D, Rüegg C, Merghoub T, Massi D, Tang H, Levesque MP, Dirnhofer S, Zippelius A, Hemmings BA, Wicki A.

Oncotarget. 2017 May 25;8(41):69204-69218. doi: 10.18632/oncotarget.18213. eCollection 2017 Sep 19.

5.

Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer.

Weixler B, Renetseder F, Facile I, Tosti N, Cremonesi E, Tampakis A, Delko T, Eppenberger-Castori S, Tzankov A, Iezzi G, Kettelhack C, Soysal SD, von Holzen U, Spagnoli GC, Terracciano L, Tornillo L, Droeser RA, Däster S.

Cell Oncol (Dordr). 2017 Dec;40(6):609-619. doi: 10.1007/s13402-017-0348-2. Epub 2017 Sep 21.

PMID:
28936810
6.

Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments.

Muraro MG, Muenst S, Mele V, Quagliata L, Iezzi G, Tzankov A, Weber WP, Spagnoli GC, Soysal SD.

Oncoimmunology. 2017 May 30;6(7):e1331798. doi: 10.1080/2162402X.2017.1331798. eCollection 2017.

7.

MAGE-A Antigens and Cancer Immunotherapy.

Zajac P, Schultz-Thater E, Tornillo L, Sadowski C, Trella E, Mengus C, Iezzi G, Spagnoli GC.

Front Med (Lausanne). 2017 Mar 8;4:18. doi: 10.3389/fmed.2017.00018. eCollection 2017.

8.

Expression of Indoleamine 2,3-Dioxygenase Gene Is a Feature of Poorly Differentiated Non-muscle-invasive Urothelial Cell Bladder Carcinomas.

Hudolin T, Mengus C, Coulot J, Kastelan Z, El-Saleh A, Spagnoli GC.

Anticancer Res. 2017 Mar;37(3):1375-1380.

PMID:
28314306
9.

The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer.

Governa V, Trella E, Mele V, Tornillo L, Amicarella F, Cremonesi E, Muraro MG, Xu H, Droeser R, Däster SR, Bolli M, Rosso R, Oertli D, Eppenberger-Castori S, Terracciano LM, Iezzi G, Spagnoli GC.

Clin Cancer Res. 2017 Jul 15;23(14):3847-3858. doi: 10.1158/1078-0432.CCR-16-2047. Epub 2017 Jan 20.

10.

Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment.

Däster S, Amatruda N, Calabrese D, Ivanek R, Turrini E, Droeser RA, Zajac P, Fimognari C, Spagnoli GC, Iezzi G, Mele V, Muraro MG.

Oncotarget. 2017 Jan 3;8(1):1725-1736. doi: 10.18632/oncotarget.13857.

11.

Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage.

Arriga R, Caratelli S, Coppola A, Spagnoli GC, Venditti A, Amadori S, Lanzilli G, Lauro D, Palomba P, Sconocchia T, Del Principe MI, Maurillo L, Buccisano F, Capuani B, Ferrone S, Sconocchia G.

Oncotarget. 2016 Jan 12;7(2):2070-9. doi: 10.18632/oncotarget.6529.

12.

Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.

Däster S, Eppenberger-Castori S, Hirt C, Soysal SD, Delko T, Nebiker CA, Weixler B, Amicarella F, Iezzi G, Governa V, Padovan E, Mele V, Sconocchia G, Heberer M, Terracciano L, Kettelhack C, Oertli D, Spagnoli GC, von Holzen U, Tornillo L, Droeser RA.

Oncoimmunology. 2015 May 29;4(12):e1050574. eCollection 2015 Dec.

13.

CD40 ligand-expressing recombinant vaccinia virus promotes the generation of CD8(+) central memory T cells.

Trella E, Raafat N, Mengus C, Traunecker E, Governa V, Heidtmann S, Heberer M, Oertli D, Spagnoli GC, Zajac P.

Eur J Immunol. 2016 Feb;46(2):420-31. doi: 10.1002/eji.201545554. Epub 2015 Dec 2.

14.

OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.

Weixler B, Cremonesi E, Sorge R, Muraro MG, Delko T, Nebiker CA, Däster S, Governa V, Amicarella F, Soysal SD, Kettelhack C, von Holzen UW, Eppenberger-Castori S, Spagnoli GC, Oertli D, Iezzi G, Terracciano L, Tornillo L, Sconocchia G, Droeser RA.

Oncotarget. 2015 Nov 10;6(35):37588-99. doi: 10.18632/oncotarget.5940.

15.

Why do infections cause cancer?

Antonelli G, Spagnoli GC.

Clin Microbiol Infect. 2015 Nov;21(11):967-8. doi: 10.1016/j.cmi.2015.07.008. Epub 2015 Jul 18. No abstract available.

16.

Bioreactor-engineered cancer tissue-like structures mimic phenotypes, gene expression profiles and drug resistance patterns observed "in vivo".

Hirt C, Papadimitropoulos A, Muraro MG, Mele V, Panopoulos E, Cremonesi E, Ivanek R, Schultz-Thater E, Droeser RA, Mengus C, Heberer M, Oertli D, Iezzi G, Zajac P, Eppenberger-Castori S, Tornillo L, Terracciano L, Martin I, Spagnoli GC.

Biomaterials. 2015 Sep;62:138-46. doi: 10.1016/j.biomaterials.2015.05.037. Epub 2015 May 20.

PMID:
26051518
17.

NK cells and T cells cooperate during the clinical course of colorectal cancer.

Sconocchia G, Eppenberger S, Spagnoli GC, Tornillo L, Droeser R, Caratelli S, Ferrelli F, Coppola A, Arriga R, Lauro D, Iezzi G, Terracciano L, Ferrone S.

Oncoimmunology. 2014 Aug 3;3(8):e952197. eCollection 2014.

18.

High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancer.

Däster S, Eppenberger-Castori S, Hirt C, Zlobec I, Delko T, Nebiker CA, Soysal SD, Amicarella F, Iezzi G, Sconocchia G, Heberer M, Lugli A, Spagnoli GC, Kettelhack C, Terracciano L, Oertli D, von Holzen U, Tornillo L, Droeser RA.

Dis Markers. 2014;2014:792183. doi: 10.1155/2014/792183. Epub 2014 Dec 30.

19.

"In vitro" 3D models of tumor-immune system interaction.

Hirt C, Papadimitropoulos A, Mele V, Muraro MG, Mengus C, Iezzi G, Terracciano L, Martin I, Spagnoli GC.

Adv Drug Deliv Rev. 2014 Dec 15;79-80:145-54. doi: 10.1016/j.addr.2014.05.003. Epub 2014 May 9. Review.

PMID:
24819215
20.

GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer.

Nebiker CA, Han J, Eppenberger-Castori S, Iezzi G, Hirt C, Amicarella F, Cremonesi E, Huber X, Padovan E, Angrisani B, Droeser RA, Rosso R, Bolli M, Oertli D, von Holzen U, Adamina M, Muraro MG, Mengus C, Zajac P, Sconocchia G, Zuber M, Tornillo L, Terracciano L, Spagnoli GC.

Clin Cancer Res. 2014 Jun 15;20(12):3094-106. doi: 10.1158/1078-0432.CCR-13-2774. Epub 2014 Apr 15.

21.

HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Sconocchia G, Eppenberger-Castori S, Zlobec I, Karamitopoulou E, Arriga R, Coppola A, Caratelli S, Spagnoli GC, Lauro D, Lugli A, Han J, Iezzi G, Ferrone C, Ferlosio A, Tornillo L, Droeser R, Rossi P, Attanasio A, Ferrone S, Terracciano L.

Neoplasia. 2014 Jan;16(1):31-42.

22.

Co-expression of cancer testis antigens and topoisomerase 2-alpha in triple negative breast carcinomas.

Mrklić I, Spagnoli GC, Juretić A, Pogorelić Z, Tomić S.

Acta Histochem. 2014 Jun;116(5):740-6. doi: 10.1016/j.acthis.2014.01.003. Epub 2014 Feb 18.

PMID:
24560456
23.

FGF2 induces RANKL gene expression as well as IL1β regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells.

Bocelli-Tyndall C, Trella E, Frachet A, Zajac P, Pfaff D, Geurts J, Heiler S, Barbero A, Mumme M, Resink TJ, Schaeren S, Spagnoli GC, Tyndall A.

Ann Rheum Dis. 2015 Jan;74(1):260-6. doi: 10.1136/annrheumdis-2013-204235. Epub 2013 Nov 18.

PMID:
24249810
24.

Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosis.

Hirt C, Eppenberger-Castori S, Sconocchia G, Iezzi G, Tornillo L, Terracciano L, Spagnoli GC, Droeser RA.

Oncoimmunology. 2013 Oct 1;2(10):e25990. Epub 2013 Sep 12.

25.

Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β.

Mele V, Muraro MG, Calabrese D, Pfaff D, Amatruda N, Amicarella F, Kvinlaug B, Bocelli-Tyndall C, Martin I, Resink TJ, Heberer M, Oertli D, Terracciano L, Spagnoli GC, Iezzi G.

Int J Cancer. 2014 Jun 1;134(11):2583-94. doi: 10.1002/ijc.28598. Epub 2014 Jan 30.

26.

Characterization and clinical relevance of ALDHbright populations in prostate cancer.

Le Magnen C, Bubendorf L, Rentsch CA, Mengus C, Gsponer J, Zellweger T, Rieken M, Thalmann GN, Cecchini MG, Germann M, Bachmann A, Wyler S, Heberer M, Spagnoli GC.

Clin Cancer Res. 2013 Oct 1;19(19):5361-71. doi: 10.1158/1078-0432.CCR-12-2857. Epub 2013 Aug 22.

27.

The role of 3D structure and protein conformation on the innate and adaptive immune responses to silk-based biomaterials.

Bhattacharjee M, Schultz-Thater E, Trella E, Miot S, Das S, Loparic M, Ray AR, Martin I, Spagnoli GC, Ghosh S.

Biomaterials. 2013 Nov;34(33):8161-71. doi: 10.1016/j.biomaterials.2013.07.018. Epub 2013 Jul 26.

PMID:
23896003
28.

High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.

Droeser RA, Hirt C, Eppenberger-Castori S, Zlobec I, Viehl CT, Frey DM, Nebiker CA, Rosso R, Zuber M, Amicarella F, Iezzi G, Sconocchia G, Heberer M, Lugli A, Tornillo L, Oertli D, Terracciano L, Spagnoli GC.

PLoS One. 2013 May 29;8(5):e64814. doi: 10.1371/journal.pone.0064814. Print 2013.

29.

Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma.

Hudolin T, Kastelan Z, Ilic I, Levarda-Hudolin K, Basic-Jukic N, Rieken M, Spagnoli GC, Juretic A, Mengus C.

J Transl Med. 2013 May 16;11:123. doi: 10.1186/1479-5876-11-123.

30.

Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

Droeser RA, Hirt C, Viehl CT, Frey DM, Nebiker C, Huber X, Zlobec I, Eppenberger-Castori S, Tzankov A, Rosso R, Zuber M, Muraro MG, Amicarella F, Cremonesi E, Heberer M, Iezzi G, Lugli A, Terracciano L, Sconocchia G, Oertli D, Spagnoli GC, Tornillo L.

Eur J Cancer. 2013 Jun;49(9):2233-42. doi: 10.1016/j.ejca.2013.02.015. Epub 2013 Mar 13.

PMID:
23478000
31.

T-cadherin loss promotes experimental metastasis of squamous cell carcinoma.

Philippova M, Pfaff D, Kyriakakis E, Buechner SA, Iezzi G, Spagnoli GC, Schoenenberger AW, Erne P, Resink TJ.

Eur J Cancer. 2013 May;49(8):2048-58. doi: 10.1016/j.ejca.2012.12.026. Epub 2013 Jan 29.

PMID:
23369463
32.

MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas.

Mengus C, Schultz-Thater E, Coulot J, Kastelan Z, Goluza E, Coric M, Spagnoli GC, Hudolin T.

Int J Cancer. 2013 May 15;132(10):2459-63. doi: 10.1002/ijc.27914. Epub 2012 Nov 16.

33.

Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.

Le Magnen C, Bubendorf L, Ruiz C, Zlobec I, Bachmann A, Heberer M, Spagnoli GC, Wyler S, Mengus C.

Eur J Cancer. 2013 Mar;49(4):955-63. doi: 10.1016/j.ejca.2012.09.023. Epub 2012 Oct 22.

PMID:
23089465
34.

Melanoma cells inhibit NK cell functions.

Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC.

Cancer Res. 2012 Oct 15;72(20):5428-9; author reply 5430. doi: 10.1158/0008-5472.CAN-12-1181. Epub 2012 Oct 9. No abstract available.

35.

Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia.

Sais G, Wyler S, Hudolin T, Banzola I, Mengus C, Bubendorf L, Wild PJ, Hirsch HH, Sulser T, Spagnoli GC, Provenzano M.

J Virol. 2012 Aug;86(16):8461-71. doi: 10.1128/JVI.00005-12. Epub 2012 May 30.

36.

Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes.

Moeller I, Spagnoli GC, Finke J, Veelken H, Houet L.

Cancer Immunol Immunother. 2012 Nov;61(11):2079-90. doi: 10.1007/s00262-012-1272-y. Epub 2012 May 6.

PMID:
22562379
37.

Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.

Raafat N, Sadowski-Cron C, Mengus C, Heberer M, Spagnoli GC, Zajac P.

Int J Cancer. 2012 Sep 1;131(5):E659-69. doi: 10.1002/ijc.27362. Epub 2012 Jan 3.

38.

Expression of cancer-testis antigens MAGE-A4 and MAGE-C1 in oral squamous cell carcinoma.

Montoro JR, Mamede RC, Neder Serafini L, Saggioro FP, Figueiredo DL, Silva WA Jr, Jungbluth AA, Spagnoli GC, Zago MA.

Head Neck. 2012 Aug;34(8):1123-8. doi: 10.1002/hed.21880. Epub 2011 Nov 15.

PMID:
22083937
39.

Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer.

Mengus C, Le Magnen C, Trella E, Yousef K, Bubendorf L, Provenzano M, Bachmann A, Heberer M, Spagnoli GC, Wyler S.

J Transl Med. 2011 Sep 26;9:162. doi: 10.1186/1479-5876-9-162.

40.

Paradoxical effects of T-cadherin on squamous cell carcinoma: up- and down-regulation increase xenograft growth by distinct mechanisms.

Pfaff D, Philippova M, Kyriakakis E, Maslova K, Rupp K, Buechner SA, Iezzi G, Spagnoli GC, Erne P, Resink TJ.

J Pathol. 2011 Dec;225(4):512-24. doi: 10.1002/path.2900. Epub 2011 Jul 15.

PMID:
21766307
41.

MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.

Schultz-Thater E, Piscuoglio S, Iezzi G, Le Magnen C, Zajac P, Carafa V, Terracciano L, Tornillo L, Spagnoli GC.

Int J Cancer. 2011 Sep 1;129(5):1137-48. doi: 10.1002/ijc.25777. Epub 2011 Jan 12.

42.

Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study.

Matković B, Juretić A, Spagnoli GC, Separović V, Gamulin M, Separović R, Sarić N, Basić-Koretić M, Novosel I, Kruslin B.

Croat Med J. 2011 Apr 15;52(2):171-7.

43.

Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?

Adams S, Greeder L, Reich E, Shao Y, Fosina D, Hanson N, Tassello J, Singh B, Spagnoli GC, Demaria S, Jungbluth AA.

Cancer Immunol Immunother. 2011 Jul;60(7):999-1007. doi: 10.1007/s00262-011-1005-7. Epub 2011 Apr 5.

44.

High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynx.

Figueiredo DL, Mamede RC, Spagnoli GC, Silva WA Jr, Zago M, Neder L, Jungbluth AA, Saggioro FP.

Head Neck. 2011 May;33(5):702-7. doi: 10.1002/hed.21522. Epub 2010 Sep 30.

PMID:
20886663
45.

Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.

Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, Patsouris ES, Peros G, Horcic M, Tornillo L, Zuber M, Droeser R, Muraro MG, Mengus C, Oertli D, Ferrone S, Terracciano L, Spagnoli GC.

Int J Cancer. 2011 Jun 1;128(11):2663-72. doi: 10.1002/ijc.25609. Epub 2010 Oct 13.

46.

Cancer-testis antigen expression in triple-negative breast cancer.

Curigliano G, Viale G, Ghioni M, Jungbluth AA, Bagnardi V, Spagnoli GC, Neville AM, Nolè F, Rotmensz N, Goldhirsch A.

Ann Oncol. 2011 Jan;22(1):98-103. doi: 10.1093/annonc/mdq325. Epub 2010 Jul 7.

PMID:
20610479
47.

Contemporary immunotherapy of solid tumors: from tumor-associated antigens to combination treatments.

Spagnoli GC, Ebrahimi M, Iezzi G, Mengus C, Zajac P.

Curr Opin Drug Discov Devel. 2010 Mar;13(2):184-92. Review.

PMID:
20205052
48.

Modulation of T-cell activation by malignant melanoma initiating cells.

Schatton T, Schütte U, Frank NY, Zhan Q, Hoerning A, Robles SC, Zhou J, Hodi FS, Spagnoli GC, Murphy GF, Frank MH.

Cancer Res. 2010 Jan 15;70(2):697-708. doi: 10.1158/0008-5472.CAN-09-1592. Epub 2010 Jan 12.

49.

Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer.

Pastorcic-Grgic M, Sarcevic B, Dosen D, Juretic A, Spagnoli GC, Grgic M.

Head Neck. 2010 Sep;32(9):1178-84. doi: 10.1002/hed.21314.

PMID:
20029985
50.

Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma.

Adamina M, Rosenthal R, Weber WP, Frey DM, Viehl CT, Bolli M, Huegli RW, Jacob AL, Heberer M, Oertli D, Marti W, Spagnoli GC, Zajac P.

Mol Ther. 2010 Mar;18(3):651-9. doi: 10.1038/mt.2009.275. Epub 2009 Nov 24.

Supplemental Content

Loading ...
Support Center